IDYA logo

IDEAYA Biosciences, Inc. (IDYA) Cash From Financing

Annual CFF:

$677.55M+$314.83M(+86.80%)
December 31, 2024

Summary

  • As of today, IDYA annual cash from financing is $677.55 million, with the most recent change of +$314.83 million (+86.80%) on December 31, 2024.
  • During the last 3 years, IDYA annual cash from financing has risen by +$532.10 million (+365.82%).
  • IDYA annual cash from financing is now at all-time high.

Performance

1-Year Change

+86.8%

3-Year Change

+365.82%

5-Year Change

+1238.77%

15-Year Change

+3773.93%

IDYA Cash From Financing Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector Percentile

98.09%
IDYA annual cash from financing is higher than 98.09% of companies in Healthcare sector

Range

All-Time High

$677.55M
IDYA annual cash from financing is currently at an all-time high

3-Year Low

$97.17M
IDYA annual cash from financing is currently +597.32% above its 3-year low

Earnings dates

Last Annual Earnings Report Date

Dec 31, 2024
IDYA previous annual earnings announcement was published on Dec 31, 2024

Next Annual Earnings Report Date

Feb 10, 2026
IDYA next annual earnings announcement is scheduled for Feb 10, 2026

OtherIDYAcash flow metrics

Annual CFI

-$502.56M
IDYA annual cash from investing is -$502.56 million

Annual CFO

-$247.58M
IDYA annual cash from operations is -$247.58 million

Annual FCF

-$251.44M
IDYA annual free cash flow is -$251.44 million

Annual CAPEX

$3.86M
IDYA annual capital expenditures is $3.86 million

Quarterly CFF:

$301.00K-$904.00K(-75.02%)
September 30, 2025

Summary

  • As of today, IDYA quarterly cash from financing is $301.00 thousand, with the most recent change of -$904.00 thousand (-75.02%) on September 30, 2025.
  • Over the past year, IDYA quarterly cash from financing has dropped by -$286.20 million (-99.89%).
  • IDYA quarterly cash from financing is now -99.91% below its all-time high of $349.11 million, reached on March 31, 2024.

Performance

3-Month Change

-75.02%

1-Year Change

-99.89%

3-Year Change

-99.69%

5-Year Change

-98.89%

IDYA Quarterly Cash From Financing Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector Percentile

52.05%
IDYA quarterly cash from financing is higher than 52.05% of companies in Healthcare sector

Range

All-Time High

$349.11M
IDYA quarterly cash from financing is currently -99.91% below its historical high of $349.11 million

3-Year Low

$301.00K
IDYA quarterly cash from financing is currently at its 3-year low

Earnings dates

Last Quarterly Earnings Report Date

Sep 30, 2025
IDYA previous earnings announcement was published on Sep 30, 2025

Next Quarterly Earnings Report Date

Feb 10, 2026
IDYA next earnings announcement is scheduled for Feb 10, 2026

OtherIDYAcash flow metrics

Quarterly CFI

$41.77M
IDYA quarterly cash from investing is $41.77 million

Quarterly CFO

$142.21M
IDYA quarterly cash from operations is $142.21 million

Quarterly FCF

$142.17M
IDYA quarterly free cash flow is $142.17 million

Quarterly CAPEX

$42.00K
IDYA quarterly capital expenditures is $42.00 thousand

TTM CFF:

$30.40M-$286.20M(-90.40%)
September 30, 2025

Summary

  • As of today, IDYA TTM cash from financing is $30.40 million, with the most recent change of -$286.20 million (-90.40%) on September 30, 2025.
  • Over the past year, IDYA TTM cash from financing has dropped by -$785.29 million (-96.27%).
  • IDYA TTM cash from financing is now -96.27% below its all-time high of $815.69 million, reached on September 30, 2024.

Performance

3-Month Change

-90.4%

1-Year Change

-96.27%

3-Year Change

-68.83%

5-Year Change

-75.05%

IDYA TTM Cash From Financing Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector Percentile

74.6%
IDYA TTM cash from financing is higher than 74.6% of companies in Healthcare sector

Range

All-Time High

$815.69M
IDYA TTM cash from financing is currently -96.27% below its historical high of $815.69 million

3-Year Low

$30.40M
IDYA TTM cash from financing is currently at its 3-year low

Earnings dates

Last Quarterly Earnings Report Date

Sep 30, 2025
IDYA previous earnings announcement was published on Sep 30, 2025

Next Quarterly Earnings Report Date

Feb 10, 2026
IDYA next earnings announcement is scheduled for Feb 10, 2026

OtherIDYAcash flow metrics

TTM CFI

-$29.61M
IDYA TTM cash from investing is -$29.61 million

TTM CFO

-$102.26M
IDYA TTM cash from operations is -$102.26 million

TTM FCF

-$105.39M
IDYA TTM free cash flow is -$105.39 million

TTM CAPEX

$3.14M
IDYA TTM capital expenditures is $3.14 million

Cash From Financing Formula

CFF = Cash Inflows from Financing Activities − Cash Outflows from Financing Activities

IDYA Cash From Financing Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1Y1 Year+86.8%-99.9%-96.3%
3Y3 Years+365.8%-99.7%-68.8%
5Y5 Years+1238.8%-98.9%-75.0%

IDYA Cash From Financing Highs & Lows

PeriodPeriodAnnual vs HighAnnual vs HighAnnual vs LowAnnual vs LowQuarter. vs HighQuarter. vs HighQuarter. vs LowQuarter. vs LowTTM vs HighTTM vs HighTTM vs LowTTM vs Low
3Y3-Yearat high+597.3%-99.9%at low-96.3%at low
5Y5-Yearat high+1238.8%-99.9%at low-96.3%at low
All-TimeAll-Timeat high+3773.9%-99.9%+136.4%-96.3%+3943.5%

IDYA Cash From Financing History

DateAnnualQuarterlyTTM
Sep 2025
-
$301.00K(-75.0%)
$30.40M(-90.4%)
Jun 2025
-
$1.21M(-95.4%)
$316.61M(-10.7%)
Mar 2025
-
$26.14M(+849.6%)
$354.58M(-47.7%)
Dec 2024
$677.55M(+86.8%)
$2.75M(-99.0%)
$677.55M(-16.9%)
Sep 2024
-
$286.50M(+631.2%)
$815.69M(+46.4%)
Jun 2024
-
$39.18M(-88.8%)
$557.02M(-21.4%)
Mar 2024
-
$349.11M(+147.8%)
$708.90M(+95.4%)
Dec 2023
$362.72M(+273.3%)
$140.89M(+406.2%)
$362.72M(+63.3%)
Sep 2023
-
$27.83M(-85.4%)
$222.15M(-23.4%)
Jun 2023
-
$191.06M(+6429.8%)
$290.01M(+191.6%)
Mar 2023
-
$2.93M(+803.1%)
$99.44M(+2.3%)
Dec 2022
$97.17M(-33.2%)
$324.00K(-99.7%)
$97.17M(-0.4%)
Sep 2022
-
$95.70M(>+9900.0%)
$97.53M(+10.1%)
Jun 2022
-
$491.00K(-24.8%)
$88.61M(-14.9%)
Mar 2022
-
$653.00K(-5.1%)
$104.10M(-28.4%)
Dec 2021
$145.45M
$688.00K(-99.2%)
$145.45M(-4.1%)
DateAnnualQuarterlyTTM
Sep 2021
-
$86.78M(+442.8%)
$151.72M(+64.9%)
Jun 2021
-
$15.99M(-61.9%)
$92.01M(-46.1%)
Mar 2021
-
$42.00M(+504.5%)
$170.72M(+32.6%)
Dec 2020
$128.75M(+154.4%)
$6.95M(-74.3%)
$128.75M(+5.7%)
Sep 2020
-
$27.07M(-71.4%)
$121.84M(+28.9%)
Jun 2020
-
$94.70M(>+9900.0%)
$94.50M(+83.6%)
Mar 2020
-
$34.00K(-10.5%)
$51.47M(+1.7%)
Dec 2019
$50.61M(-52.0%)
$38.00K(+113.8%)
$50.61M(+0.1%)
Sep 2019
-
-$276.00K(-100.5%)
$50.57M(-0.6%)
Jun 2019
-
$51.67M(+6355.9%)
$50.89M(+6533.5%)
Mar 2019
-
-$826.00K(-2114.6%)
-$791.00K(-100.8%)
Dec 2018
$105.38M(+502.5%)
-
-
Sep 2018
-
$41.00K(+783.3%)
$105.45M(+0.0%)
Jun 2018
-
-$6000.00(-100.0%)
$105.41M(-0.0%)
Mar 2018
-
$105.42M
$105.42M
Dec 2017
$17.49M
-
-

FAQ

  • What is IDEAYA Biosciences, Inc. annual cash from financing?
  • What is the all-time high annual cash from financing for IDEAYA Biosciences, Inc.?
  • What is IDEAYA Biosciences, Inc. annual cash from financing year-on-year change?
  • What is IDEAYA Biosciences, Inc. quarterly cash from financing?
  • What is the all-time high quarterly cash from financing for IDEAYA Biosciences, Inc.?
  • What is IDEAYA Biosciences, Inc. quarterly cash from financing year-on-year change?
  • What is IDEAYA Biosciences, Inc. TTM cash from financing?
  • What is the all-time high TTM cash from financing for IDEAYA Biosciences, Inc.?
  • What is IDEAYA Biosciences, Inc. TTM cash from financing year-on-year change?

What is IDEAYA Biosciences, Inc. annual cash from financing?

The current annual cash from financing of IDYA is $677.55M

What is the all-time high annual cash from financing for IDEAYA Biosciences, Inc.?

IDEAYA Biosciences, Inc. all-time high annual cash from financing is $677.55M

What is IDEAYA Biosciences, Inc. annual cash from financing year-on-year change?

Over the past year, IDYA annual cash from financing has changed by +$314.83M (+86.80%)

What is IDEAYA Biosciences, Inc. quarterly cash from financing?

The current quarterly cash from financing of IDYA is $301.00K

What is the all-time high quarterly cash from financing for IDEAYA Biosciences, Inc.?

IDEAYA Biosciences, Inc. all-time high quarterly cash from financing is $349.11M

What is IDEAYA Biosciences, Inc. quarterly cash from financing year-on-year change?

Over the past year, IDYA quarterly cash from financing has changed by -$286.20M (-99.89%)

What is IDEAYA Biosciences, Inc. TTM cash from financing?

The current TTM cash from financing of IDYA is $30.40M

What is the all-time high TTM cash from financing for IDEAYA Biosciences, Inc.?

IDEAYA Biosciences, Inc. all-time high TTM cash from financing is $815.69M

What is IDEAYA Biosciences, Inc. TTM cash from financing year-on-year change?

Over the past year, IDYA TTM cash from financing has changed by -$785.29M (-96.27%)
On this page